Stereotactic radiation therapy in early stage NSCLC
Stereotactic body radiation therapy (SBRT) is a method of delivering ablative doses of radiation safely. Typically large doses (7.5 - 20Gy) are given over a few fractions (i.e. 1-8 fractions over 1 to 2 weeks).
SBRT or Steretactic body ablative radiotherepy (SABR) can be an effective treatment for early stage non-small cell lung cancer.
To read the article written for Biotechnology Focus January 2012 - click here (the article appears on page 11).
SBRT or Steretactic body ablative radiotherepy (SABR) can be an effective treatment for early stage non-small cell lung cancer.
To read the article written for Biotechnology Focus January 2012 - click here (the article appears on page 11).